|
US447475A
(en)
|
|
1891-03-03 |
|
pomerof |
|
US4188373A
(en)
|
1976-02-26 |
1980-02-12 |
Cooper Laboratories, Inc. |
Clear, water-miscible, liquid pharmaceutical vehicles and compositions which gel at body temperature for drug delivery to mucous membranes
|
|
US4522811A
(en)
|
1982-07-08 |
1985-06-11 |
Syntex (U.S.A.) Inc. |
Serial injection of muramyldipeptides and liposomes enhances the anti-infective activity of muramyldipeptides
|
|
US4474751A
(en)
|
1983-05-16 |
1984-10-02 |
Merck & Co., Inc. |
Ophthalmic drug delivery system utilizing thermosetting gels
|
|
US4478822A
(en)
|
1983-05-16 |
1984-10-23 |
Merck & Co., Inc. |
Drug delivery system utilizing thermosetting gels
|
|
US5346703A
(en)
|
1990-08-07 |
1994-09-13 |
Mediventures, Inc. |
Body cavity drug delivery with thermo-irreversible polyoxyalkylene and ionic polysaccharide gels
|
|
EP1109563A4
(en)
|
1998-08-04 |
2009-07-22 |
Madash Llp |
AT THE END MODIFIED HYDROGELE WITH TEMPERATURE DEPENDENT FEATURES
|
|
US6761824B2
(en)
|
2000-08-17 |
2004-07-13 |
Reeve Lorraine E |
Process for the fractionation of polymers
|
|
WO2009009737A1
(en)
*
|
2007-07-12 |
2009-01-15 |
Neurosci, Inc. |
Sustained release formulation of active pharmaceuticals in a lipid based sustained release
|
|
US8188131B2
(en)
|
2008-02-07 |
2012-05-29 |
Massachusetts Eye & Ear Infirmary |
Compounds that enhance Atoh1 expression
|
|
AR087107A1
(es)
|
2011-07-27 |
2014-02-12 |
Lilly Co Eli |
Compuesto inhibidor de la señalizacion de la trayectoria notch
|
|
EP2606884A1
(en)
|
2011-12-21 |
2013-06-26 |
Ecole Polytechnique Fédérale de Lausanne (EPFL) |
Inhibitors of notch signaling pathway and use thereof in treatment of cancers
|
|
US9828344B2
(en)
|
2012-06-01 |
2017-11-28 |
LEIBNIZ-INSTITUT FÜR ALTERSFORSCHUNG FRITZ-LIPMANN-INSTITUT e.V. (FLI) |
Inhibitors of the notch signaling pathway and secretion for use in medicine
|
|
US20150209367A1
(en)
|
2012-09-07 |
2015-07-30 |
Massachusetts Eye & Ear Infirmary |
Treating Hearing Loss
|
|
CN104797569A
(zh)
|
2012-09-21 |
2015-07-22 |
百时美施贵宝公司 |
取代的1,5-苯并二氮杂*酮化合物
|
|
EP2897942B1
(en)
|
2012-09-21 |
2016-08-31 |
Bristol-Myers Squibb Company |
Fluoroalkyl and fluorocycloalkyl 1,4-benzodiazepinone compounds as notch inhibitors
|
|
WO2014047370A1
(en)
|
2012-09-21 |
2014-03-27 |
Bristol-Myers Squibb Company |
Fluoroalkyl dibenzodiazepinone compounds
|
|
JP2015531792A
(ja)
|
2012-09-21 |
2015-11-05 |
ブリストル−マイヤーズ スクイブ カンパニーＢｒｉｓｔｏｌ−Ｍｙｅｒｓ Ｓｑｕｉｂｂ Ｃｏｍｐａｎｙ |
１，４−ベンゾジアゼピノン化合物のプロドラッグ
|
|
CN105308030A
(zh)
|
2012-09-21 |
2016-02-03 |
百时美施贵宝公司 |
烷基、氟烷基-1,4-苯并二氮杂*酮化合物
|
|
UA110688C2
(uk)
|
2012-09-21 |
2016-01-25 |
Пфайзер Інк. |
Біциклічні піридинони
|
|
TWI614238B
(zh)
|
2012-09-21 |
2018-02-11 |
必治妥美雅史谷比公司 |
雙（氟烷基）－１，４－苯并二氮呯酮化合物及其前藥
|
|
CN104797584A
(zh)
|
2012-09-21 |
2015-07-22 |
百时美施贵宝公司 |
作为notch抑制剂的三环杂环化合物
|
|
WO2014047392A1
(en)
|
2012-09-21 |
2014-03-27 |
Bristol-Myers Squibb Company |
Fluoroalkyl-1,4-benzodiazepinone compounds
|
|
US9572815B2
(en)
|
2013-03-15 |
2017-02-21 |
St. Jude Children's Research Hospital |
Methods and compositions of p27KIP1 transcriptional modulators
|
|
CN103169649A
(zh)
*
|
2013-04-11 |
2013-06-26 |
中国人民解放军总医院 |
温度和离子双重敏感型原位凝胶鼻腔给药系统
|
|
WO2016022776A2
(en)
|
2014-08-06 |
2016-02-11 |
Massachusetts Eye And Ear Infirmary |
Increasing atoh1 life to drive sensorineural hair cell differentiantion
|
|
EP3189134A1
(en)
*
|
2014-09-03 |
2017-07-12 |
The Brigham and Women's Hospital, Inc. |
Compositions, systems, and methods for generating inner ear hair cells for treatment of hearing loss
|
|
US20170304369A1
(en)
|
2014-10-08 |
2017-10-26 |
Agency For Science, Technology And Research |
Methods of differentiating stem cells into liver cell lineages
|
|
JO3491B1
(ar)
|
2015-07-07 |
2020-07-05 |
Audion Therapeutics |
مركبات مثبطة لإشارات مسار notch
|
|
US20180353875A1
(en)
|
2015-12-22 |
2018-12-13 |
Basf Se |
A process for purification of polyether block copolymers
|
|
US10201540B2
(en)
*
|
2016-03-02 |
2019-02-12 |
Frequency Therapeutics, Inc. |
Solubilized compositions for controlled proliferation of stem cells / generating inner ear hair cells using GSK3 inhibitors: I
|
|
US10213511B2
(en)
*
|
2016-03-02 |
2019-02-26 |
Frequency Therapeutics, Inc. |
Thermoreversible compositions for administration of therapeutic agents
|
|
CN109311878B
(zh)
|
2016-06-27 |
2022-05-24 |
豪夫迈·罗氏有限公司 |
作为γ-分泌酶调节剂的三唑并吡啶类化合物
|
|
WO2018007331A1
(en)
|
2016-07-08 |
2018-01-11 |
F. Hoffmann-La Roche Ag |
Fused pyrimidine derivatives
|
|
WO2018011164A1
(en)
|
2016-07-14 |
2018-01-18 |
F. Hoffmann-La Roche Ag |
Fused pyrimidine derivatives
|
|
AR109829A1
(es)
|
2016-09-29 |
2019-01-30 |
Hoffmann La Roche |
Derivados de piperidina puenteados
|
|
JP6956175B2
(ja)
|
2016-10-04 |
2021-11-02 |
エフ．ホフマン−ラ ロシュ アーゲーＦ． Ｈｏｆｆｍａｎｎ−Ｌａ Ｒｏｃｈｅ Ａｋｔｉｅｎｇｅｓｅｌｌｓｃｈａｆｔ |
二環式ヘテロアリール誘導体
|
|
AR110122A1
(es)
|
2016-11-08 |
2019-02-27 |
Hoffmann La Roche |
Fenoxitriazoles
|
|
WO2018111926A2
(en)
|
2016-12-16 |
2018-06-21 |
Inception 3, Inc. |
Methods of treating cochlear synaptopathy
|
|
EP4252856A3
(en)
|
2016-12-20 |
2024-01-24 |
Oligomerix, Inc. |
Novel quinazolinones that inhibit the formation of tau oligomers and their method of use
|
|
EP3562483B1
(en)
|
2016-12-20 |
2025-09-03 |
Oligomerix, Inc. |
Novel benzofuran, benzothiophene, and indole analogs that inhibit the formation of tau oligomers and their method of use
|
|
EP3562827A1
(en)
|
2016-12-30 |
2019-11-06 |
Frequency Therapeutics, Inc. |
1h-pyrrole-2,5-dione compounds and methods of using them to induce self-renewal of stem/progenitor supporting cells
|
|
US10383881B2
(en)
|
2016-12-30 |
2019-08-20 |
Frequency Therapeutics, Inc. |
1,5-dihydro-2H-pyrrol-2-one compounds and methods of using same
|
|
EP3601276A1
(en)
|
2017-03-24 |
2020-02-05 |
Novartis AG |
Isoxazole carboxamide compounds and uses thereof
|